Peter Blurton

470 total citations
10 papers, 394 citations indexed

About

Peter Blurton is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Peter Blurton has authored 10 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Peter Blurton's work include Neuroscience and Neuropharmacology Research (3 papers), Pharmacological Receptor Mechanisms and Effects (3 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (3 papers). Peter Blurton is often cited by papers focused on Neuroscience and Neuropharmacology Research (3 papers), Pharmacological Receptor Mechanisms and Effects (3 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (3 papers). Peter Blurton collaborates with scholars based in United Kingdom and United States. Peter Blurton's co-authors include Stephen R. Fletcher, Ruth M. McKernan, C I Ragan, Kathleen Quirk, Paul D. Leeson, Flora Tang, R.B. Clarkson, Linda J. Bristow, Peter H. Hutson and Cheryl L. Barton and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Cancer and Neuropharmacology.

In The Last Decade

Peter Blurton

10 papers receiving 377 citations

Peers

Peter Blurton

CMN

PHYSI

Shengming Huang United States

A. Brambilla Italy

Austin J. Reeve United States

Rita Dost Germany

Emilia Rivas Spain

Makoto Oka Japan

Alan E. Fletcher United States

Willy P. Burkard Switzerland

Richard A. Jelley United Kingdom

Stanley Nawoschik United States

Shengming Huang United States

Peter Blurton

279 ×1.3

CMN

258 ×1.3

59 ×0.6

68 ×0.9

41 ×1.5

PHYSI

Citations per year, relative to Peter Blurton Peter Blurton (= 1×) peers Shengming Huang

Countries citing papers authored by Peter Blurton

Since Specialization

Citations

This map shows the geographic impact of Peter Blurton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Blurton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Blurton more than expected).

Fields of papers citing papers by Peter Blurton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Blurton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Blurton. The network helps show where Peter Blurton may publish in the future.

Co-authorship network of co-authors of Peter Blurton

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Blurton. A scholar is included among the top collaborators of Peter Blurton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Blurton. Peter Blurton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Higgins, Catherine, Joanna Majkut, Margarita Espona‐Fiedler, et al.. (2016). Development and pre-clinical assessment of a first-in-class small molecule inhibitor of FLIP for treatment of NSCLC and CRC. European Journal of Cancer. 69. S6–S6. 2 indexed citations

Pollack, Scott J., Kim S. Beyer, Christopher Lock, et al.. (2011). A comparative study of fragment screening methods on the p38α kinase: new methods, new insights. Journal of Computer-Aided Molecular Design. 25(7). 677–687. 26 indexed citations

Zheng, Xiaozhang, Kevin J. Hodgetts, Harry L. Brielmann, et al.. (2006). From arylureas to biarylamides to aminoquinazolines: Discovery of a novel, potent TRPV1 antagonist. Bioorganic & Medicinal Chemistry Letters. 16(19). 5217–5221. 25 indexed citations

Atack, John, Peter Blurton, Robert W. Carling, et al.. (2004). 2,5-Dihydropyrazolo[4,3-c]pyridin-3-ones: functionally selective benzodiazepine binding site ligands on the GABAA receptor. Bioorganic & Medicinal Chemistry Letters. 14(13). 3441–3444. 18 indexed citations

Fletcher, Stephen R., Peter Blurton, R.B. Clarkson, et al.. (2001). 4-(Phenylsulfonyl)piperidines: Novel, Selective, and Bioavailable 5-HT_2AReceptor Antagonists. Journal of Medicinal Chemistry. 45(2). 492–503. 44 indexed citations

Hutson, Peter H., et al.. (2000). Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT2C/2B receptor antagonists: neurochemical and behavioural studies. Neuropharmacology. 39(12). 2318–2328. 59 indexed citations

Dhanak, Dashyant, et al.. (1997). Palladium Catalysed Coupling of Iodoquinolines and Acetylenes -- A Novel Entry to the Pyrrolo[3,2,1-ij]quinoline Nucleus. Heterocycles. 45(12). 2395–2395. 14 indexed citations

Quirk, Kathleen, Peter Blurton, Stephen R. Fletcher, et al.. (1996). [ 3 H]L-655,708, a Novel Ligand Selective for the Benzodiazepine Site of GABA A Receptors which Contain the α5 Subunit. Neuropharmacology. 35(9-10). 1331–1335. 155 indexed citations

Ife, Robert J., Thomas H. Brown, Peter Blurton, et al.. (1995). Reversible Inhibitors of the Gastric (H+/K+)-ATPase. 5. Substituted 2,4-Diaminoquinazolines and Thienopyrimidines. Journal of Medicinal Chemistry. 38(14). 2763–2773. 38 indexed citations

10.

Brown, Theodore J., et al.. (1989). Isocytosine H2-receptor histamine antagonists II. Synthesis and evaluation of biological activity at histamine H1- and H2-receptors of 5-(heterocyclyl)methylisocytosines. European Journal of Medicinal Chemistry. 24(1). 65–72. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact